Viewing Study NCT04851535


Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2025-12-25 @ 8:05 PM
Study NCT ID: NCT04851535
Status: COMPLETED
Last Update Posted: 2023-11-03
First Post: 2021-04-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module